Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Acetaminophen Panel To Mull Expanded Dosing, Standard Solid Concentration

This article was originally published in The Tan Sheet

Executive Summary

FDA is asking a joint advisory panel to consider whether it should restrict firms to one standard acetaminophen concentration for all solid oral dosage single-ingredient pediatric products, among other measures to reduce dosing errors.

You may also be interested in...



OTC Survey Underscores Label Communication Challenges

An Edelman survey shows high consumer regard for OTC safety, efficacy and value, but finds that 24% of the 1,035 consumers surveyed have taken more than the indicated dosage of an OTC medicine to “more effectively treat their symptoms.”

OTC Survey Underscores Label Communication Challenges

An Edelman survey shows high consumer regard for OTC safety, efficacy and value, but finds that 24% of the 1,035 consumers surveyed have taken more than the indicated dosage of an OTC medicine to “more effectively treat their symptoms.”

McNeil Recalls Liquid Infants’ Tylenol With Dosing Device Problem

McNeil Consumer Healthcare recalls an Infants’ Tylenol product that returned to market in November, after receiving consumer complaints about a problem with the SimpleMeasure dosing device system. The recall marks a misstep in the J&J subsidiary’s comeback from OTC quality control issues.

Related Content

Topics

UsernamePublicRestriction

Register

PS105044

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel